The 3.2 Å Structure of a Bioengineered Variant of Blood Coagulation Factor VIII Indicates Two Conformations of the C2 Domain

BACKGROUND: Coagulation factor VIII represents one of the oldest protein-based therapeutics, serving as an effective hemophilia A treatment for half a century. Optimal treatment consists of repeated intravenous infusions of blood coagulation factor VIII (FVIII) per week for life. Despite overall tre...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Thromb Haemost
Asıl Yazarlar: Smith, Ian W., d’Aquino, Anne E., Coyle, Christopher W., Fedanov, Andrew, Parker, Ernest T., Denning, Gabriela, Spencer, H. Trent, Lollar, Pete, Doering, Christopher B., Spiegel, P. Clint
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6940532/
https://ncbi.nlm.nih.gov/pubmed/31454152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.14621
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller